erlotinib hydrochloride has been researched along with singlet oxygen in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (singlet oxygen) | Trials (singlet oxygen) | Recent Studies (post-2010) (singlet oxygen) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 3,870 | 4 | 2,322 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Chen, J; Huo, B; Li, D; Song, M; Xue, J; Yuan, G; Zhang, F; Zhao, X | 1 |
1 other study(ies) available for erlotinib hydrochloride and singlet oxygen
| Article | Year |
|---|---|
Epidermal Growth Factor Receptor-Targeted Delivery of a Singlet-Oxygen Sensitizer with Thermal Controlled Release for Efficient Anticancer Therapy.
Topics: Animals; Cell Line, Tumor; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Screening Assays, Antitumor; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Injections, Intravenous; Mice; Neoplasms; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2019 |